BN ImmunoTherapeutics Starts Clinical Trials With Prostate Cancer ...

BN ImmunoTherapeutics Starts Clinical Trials With Prostate Cancer ...

FOXBusiness

A Phase I/II safety and tolerability study in 18 male patients with non-metastatic as well as hormone-insensitive prostate cancer has begun enrolment in the ...


Readmore...

[Source : Google News]

Tags: prostate, cancer, prostate cancer, health, Immunotherapeutics